Gunday, Marisa M.
HRN: 24-70-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
MUPIROCIN 2%, 15G (TUBE)
04/10/2024
04/17/2024
TOPICAL
2%
Once A Day
Blister
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes